Anti-tumor activity of fucoidan is mediated by nitric oxide released from macrophages

Fucoidan, a sulfated polysaccharide, has significant cytotoxic activity against tumor cells; however, the mechanism(s) of this action remains poorly understood. The present study was designed to determine the in vitro and in vivo effects of fucoidan and their molecular mechanisms. Fucoidan from Clad...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of oncology Vol. 40; no. 1; pp. 251 - 260
Main Authors TAKEDA, Kaori, TOMIMORI, Koh, KIMURA, Ryuichiro, ISHIKAWA, Chie, NOWLING, Tamara K, MORI, Naoki
Format Journal Article
LanguageEnglish
Published Athens Editorial Academy of the International Journal of Oncology 01.01.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Fucoidan, a sulfated polysaccharide, has significant cytotoxic activity against tumor cells; however, the mechanism(s) of this action remains poorly understood. The present study was designed to determine the in vitro and in vivo effects of fucoidan and their molecular mechanisms. Fucoidan from Cladosiphon okamuranus Tokida cultivated in Okinawa, Japan, delayed tumor growth in Sarcoma 180 (S-180)-bearing mice. However, it failed to inhibit S-180 cell growth in vitro. Activated macrophages are known to have anti-tumor effects. Murine RAW264.7 macrophages stimulated with fucoidan exerted cytotoxicity towards S-180 cells in vitro. This cytotoxicity was associated with nitric oxide (NO) production. Both cytocidal effect and NO production were significantly inhibited by L-NAME, an inhibitor of NO synthase (NOS). Furthermore, activation of nuclear factor-κB was a key step in the transcriptional activation of the inducible NOS gene. Taken together, our results indicate that the anti-tumor activity of fucoidan on S-180 cells is mediated through increased NO production by fucoidan-stimulated macrophages via nuclear factor-κB-dependent signaling pathway.
ISSN:1019-6439
1791-2423
DOI:10.3892/ijo.2011.1168